GPR183 and B-cell chronic lymphocytic leukemia: Conversely, EBI2 overexpression leads to B1a cell expansion, diminished immune responses, oncogene activation, and late-onset lymphoid malignancies, resembling features of chronic lymphocytic leukemia (CLL) (101).